Test Price
2,800 AED✅ Home Collection Available
ZNF81 Gene X-Linked Intellectual Disability Type 45 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين ZNF81 للإعاقة الذهنية المرتبطة بالكروموسوم X النوع 45 في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary & Clinical Confidence
The targeted Next-Generation Sequencing (NGS) assay for the ZNF81 gene detects pathogenic variants linked to X-linked intellectual disability type 45 (formerly mental retardation, X-linked type 45) with 99.9% diagnostic sensitivity. All testing is performed under ISO 9001:2015 certified facilities (Cert: INT/EGQ/2509DA/3139) and in strict compliance with UAE Federal Decree-Law No. 41 of 2024 (Art. 87), CDS Law 2026 (minors require parental consent), and UAE Personal Data Protection Law. Your genetic data is encrypted and never shared outside the DHA‑awarded laboratory.
الفحص الجيني لجين ZNF81 للإعاقة الذهنية المرتبطة بالكروموسوم X بدقة تشخيصية 99.9% عبر تقنية التسلسل من الجيل التالي وبموافقة هيئة الصحة بدبي.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: Paid Hospital‑Grade Home Collection via ISO Certified Cold‑Chain Home Collection & VIP Mobile Phlebotomy (8 AM – 11 PM).
- Clinical Guidance: Post‑test telephonic clinical guidance with a neurologist to interpret results.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Overview
The ZNF81 gene test detects mutations causing X‑linked intellectual disability type 45, a neurodevelopmental disorder characterized by mild to moderate cognitive impairment, often with speech delay and behavioural abnormalities. This highly accurate NGS panel covers all coding exons and splice sites, delivering a definitive molecular diagnosis that guides clinical management, family planning, and early intervention strategies.
يكشف اختبار جين ZNF81 عن الطفرات المسببة للإعاقة الذهنية المرتبطة بالكروموسوم X من النوع 45، مما يتيح تشخيصاً جزيئياً دقيقاً وإرشاداً وراثياً.
| Parameter | Our Test (ZNF81 Single‑Gene NGS) | Closest Alternative (Whole Exome Sequencing) |
|---|---|---|
| Precision | Targeted deep coverage (>1000×) for ZNF81 – detects even low‑level mosaicism | Broad coverage (~100×) may miss low‑frequency variants in the gene |
| Methodology | NGS (Next‑Generation Sequencing) with bidirectional Sanger confirmation | NGS, often without single‑gene validation |
| Turnaround Time | 3 to 4 Weeks | 8 to 12 Weeks |
| Price | 2800 AED | 5000‑8000 AED |
Physician Insight & Safety Protocol
“As a neurologist, I understand the emotional weight a family carries when seeking answers for developmental delays. This test provides the molecular clarity needed to tailor therapies and connect you with the right support systems, but it must always be correlated with a thorough clinical evaluation and family history. A negative result does not exclude other genetic or environmental causes, and post‑test counselling is essential.” – Dr. PRABHAKAR REDDY, DHA License 61713011
Medication Warning: Do not discontinue any prescribed medication without consulting your treating physician. Genetic results can influence medication selection but must not replace clinical judgement.
Safety Exclusion Criteria & Emergency Red Flags
- Exclusion: Active uncontrolled seizure disorder or recent head trauma requiring hospitalisation — sample collection can be rescheduled upon clinical stabilisation.
- Exclusion: Patients under 18 must have a legal guardian present for consent and all home collection procedures.
- ER Red Flag: Sudden loss of consciousness, prolonged seizure (>5 minutes), or severe neuropsychiatric deterioration — proceed to the nearest emergency department immediately, regardless of genetic test scheduling.
- Sample viability: If DNA is extracted from an external lab, the extraction certificate and cold‑chain log must be presented; otherwise, a fresh blood draw is mandated.
Patient FAQ & Clinical Guidance
What exactly does the ZNF81 gene test reveal for my child’s development?
This test identifies pathogenic mutations in the ZNF81 gene that are proven to cause X‑linked intellectual disability type 45, enabling precise prognosis and early intervention plans.
يكشف الاختبار عن طفرات مرضية في جين ZNF81 تسبب الإعاقة الذهنية المرتبطة بالكروموسوم X، مما يحدد الإنذار الدقيق ويُمكن من وضع خطط التدخل المبكر.
Why should I choose this single‑gene test over a broader whole‑exome test?
Single‑gene targeted NGS delivers deeper coverage and higher analytical sensitivity for ZNF81 mutations, reducing the risk of missing low‑level variants while maintaining a faster turnaround time of 3–4 weeks.
يوفر التسلسل الجيني الموجه لجين واحد تغطية أعمق وحساسية تحليلية أعلى لطفرات ZNF81، مع نتائج أسرع خلال 3-4 أسابيع.
Is this approved by the DHA and safe for my privacy?
Our laboratory holds a DHA facility licence (9834453) and follows UAE PDPL to encrypt all genetic data; no result is ever disclosed without your explicit written consent.
مختبرنا مرخص من هيئة الصحة بدبي ويتبع قانون حماية البيانات الشخصية الإماراتي لتشفير بياناتك الجينية وعدم الإفصاح عنها دون موافقتك الخطية.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians